The US Centers for Disease Control and Prevention and the Food and Drug Administration on Tuesday recommended suspension of the drug company’s vaccine management.
Madrid (EUROPA PRESS). After the US regulator recommended that the vaccine against covid-19 be suspended, Johnson & Johnson’s stock price fell 2% on the New York Stock Exchange.
Specifically, the laboratory’s opening price was US$156.86, and Monday’s closing price was US$161.64 (-2.95%).
After the initial decline, the price softened the pace of the decline, but it remained close to 2% until the median price.
The U.S. Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) recommended on Tuesday to suspend the injection of Johnson & Johnson’s Johnson Vaccine after the discovery of six patients with possible thrombosis.
Compared with the 6.8 million vaccine shots that have been injected in the United States, the number of detections (the reason for which is still uncertain) is very low.
Based on this recommendation, Janssen decided to postpone the launch of its COVID-19 vaccine in Europe.
In view of this, European Health Commissioner Stella Kyriakides said that ensuring its safety is paramount.